Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention
Authors:
- Giuseppe PattiGPGiuseppe Patti
- Annunziata NuscaANAnnunziata Nusca
- Fabio MangiacapraFabio Mangiacapra
- Laura GattoLGLaura Gatto
- Andrea D'AMbrosioADAndrea D'AMbrosio
- Germano Di SciascioGSGermano Di Sciascio
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Universal Definition of Myocardial InfarctionJACC, 2007
- Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary InterventionJACC, 2007
- Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac SurgeryCirculation, 2006
- Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary InterventionJACC, 2006
- Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrelMethods and Findings in Experimental and Clinical Pharmacology, 2006
- Platelet Reactivity in Patients and Recurrent Events Post-StentingJACC, 2005
- Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary InterventionCirculation, 2005
- Platelet Function Testing in Cardiovascular DiseasesCirculation, 2004
- Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary InterventionCirculation, 2004
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJACC, 1988